PITPNB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.056400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.787400E-01
Normal-vs-Stage2
8.357000E-01
Normal-vs-Stage3
8.282000E-01
Normal-vs-Stage4
9.317600E-01
Stage1-vs-Stage2
6.216200E-01
Stage1-vs-Stage3
8.930000E-01
Stage1-vs-Stage4
9.179800E-01
Stage2-vs-Stage3
5.603600E-01
Stage2-vs-Stage4
7.607000E-01
Stage3-vs-Stage4
8.408600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.150000E-01
Normal-vs-AfricanAmerican
6.190800E-01
Normal-vs-Asian
8.482800E-01
Caucasian-vs-AfricanAmerican
5.307800E-01
Caucasian-vs-Asian
8.546400E-01
AfricanAmerican-vs-Asian
4.954600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.258800E-01
Normal-vs-Female
7.210600E-01
Male-vs-Female
7.720200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.358400E-01
Normal-vs-Age(41-60Yrs)
5.849200E-01
Normal-vs-Age(61-80Yrs)
9.872400E-01
Normal-vs-Age(81-100Yrs)
5.151200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.442640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.676600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.059000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.234400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.154400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.368000E-01
Normal-vs-Daily Drinker
7.857600E-01
Normal-vs-Weekly Drinker
6.454200E-01
Normal-vs-Occasional Drinker
5.802600E-01
Normal-vs-Social Drinker
8.429800E-01
Non Drinker-vs-Daily Drinker
8.159800E-01
Non Drinker-vs-Weekly Drinker
2.368400E-01
Non Drinker-vs-Occasional Drinker
1.719820E-01
Non Drinker-vs-Social Drinker
4.478600E-01
Daily Drinker-vs-Weekly Drinker
1.790440E-01
Daily Drinker-vs-Occasional Drinker
1.714580E-01
Daily Drinker-vs-Social Drinker
4.067000E-01
Weekly Drinker-vs-Occasional Drinker
7.012400E-01
Weekly Drinker-vs-Social Drinker
5.211200E-01
Occasional Drinker-vs-Social Drinker
6.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.020200E-01
Normal-vs-Grade 2
9.167200E-01
Normal-vs-Grade 3
8.911200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.738090E-03
Grade 1-vs-Grade 3
3.265600E-02
Grade 1-vs-Grade 4
8.020200E-01
Grade 2-vs-Grade 3
3.939400E-01
Grade 2-vs-Grade 4
9.167200E-01
Grade 3-vs-Grade 4
8.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.968000E-01
Normal-vs-NonDiabetic
9.271400E-01
Diabetic-vs-NonDiabetic
7.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.480000E-01
Normal-vs-NoPancreatitis
9.929200E-01
Pancreatitis-vs-NoPancreatitis
5.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.347000E-01
Normal-vs-N1
7.758000E-01
N0-vs-N1
9.612000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.583200E-01
Normal-vs-TP53-NonMutant
9.520200E-01
TP53-Mutant-vs-TP53-NonMutant
3.399700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
